Cite

HARVARD Citation

    Fortner, R. et al. (2017). Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort. BMC medicine. 15 (1), pp. 1-10. [Online]. 
  
Back to record